Abstract
The nervous and immune systems collaborate in the control of homeostasis and host defence. All divisions of the nervous system, sympathetic, parasympathetic and sensory, act to regulate immune cell function. Processes under neuronal control include antigen processing and presentation, Th1/Th2 balance, immunoglobulin production and antigen specific responses, while involvement of the central nervous system allows for behavioral changes leading to avoidance of antigen or noxious stimuli. It therefore follows that dysregulation of these complex bidirectional neuroimmune signaling systems may contribute to the aetiology and pathophysiology of immune disorders including atopic disease.
A greater understanding on how the brain perceives, processes and responds to immune challenges and how multiple neurotransmitters interact to maintain or skew the balance between tolerance and immunity will undoubtedly provide opportunities for the development of novel therapeutics. Furthermore, the implications for atopic disease of relatively recent developments such as the cholinergic antiinflammatory pathway and the potential direct antigen-specific activation of the nervous system require further exploration.
Keywords: Inflammation, brain, sympathetic nervous system, vagus, neuropeptides
Current Pharmaceutical Design
Title:The Nervous System as a Critical Regulator of Immune Responses Underlying Allergy
Volume: 18 Issue: 16
Author(s): Paul Forsythe
Affiliation:
Keywords: Inflammation, brain, sympathetic nervous system, vagus, neuropeptides
Abstract: The nervous and immune systems collaborate in the control of homeostasis and host defence. All divisions of the nervous system, sympathetic, parasympathetic and sensory, act to regulate immune cell function. Processes under neuronal control include antigen processing and presentation, Th1/Th2 balance, immunoglobulin production and antigen specific responses, while involvement of the central nervous system allows for behavioral changes leading to avoidance of antigen or noxious stimuli. It therefore follows that dysregulation of these complex bidirectional neuroimmune signaling systems may contribute to the aetiology and pathophysiology of immune disorders including atopic disease.
A greater understanding on how the brain perceives, processes and responds to immune challenges and how multiple neurotransmitters interact to maintain or skew the balance between tolerance and immunity will undoubtedly provide opportunities for the development of novel therapeutics. Furthermore, the implications for atopic disease of relatively recent developments such as the cholinergic antiinflammatory pathway and the potential direct antigen-specific activation of the nervous system require further exploration.
Export Options
About this article
Cite this article as:
Forsythe Paul, The Nervous System as a Critical Regulator of Immune Responses Underlying Allergy, Current Pharmaceutical Design 2012; 18 (16) . https://dx.doi.org/10.2174/138161212800165951
DOI https://dx.doi.org/10.2174/138161212800165951 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Transport Mechanisms at the Blood-Cerebrospinal-Fluid Barrier: Role of Megalin (LRP2)
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Recent Advances in Peptide Nucleic Acids as Antibacterial Agents
Current Medicinal Chemistry The Patenting and Technological Trends in Candidiasis Treatment: A Systematic Review (2014-2018)
Current Topics in Medicinal Chemistry Bacterial Protein Microarrays for Diagnosis of Infectious Diseases
Current Immunology Reviews (Discontinued) Efficacy of PD-1 or PD-L1 Inhibitors and Central Nervous System Metastases in Advanced Cancer: A Meta-Analysis
Current Cancer Drug Targets Evaluation of B Lymphocyte Deficiencies
Cardiovascular & Hematological Disorders-Drug Targets Structure-Activity Relationship of Dicoumarol Derivatives as anti- Staphylococcus aureus (Staph Infection) Agents
Anti-Infective Agents Caring for HIV-Infected Patients in the ICU in The Highly Active Antiretroviral Therapy Era
Current HIV Research Isolation of the Antibacterial Agent Viridiol from the Mangrove Endophytic Fungus Hypocrea virens, as Monitored by a Biologic Assay Against Escherichia coli and NMR Spectroscopy
Current Biotechnology Tuberculostatic Drugs Targeting Infections of the Central Nervous System
Anti-Infective Agents Symmetry Plane Detection in Brain Image Analysis: A Survey
Current Medical Imaging Selective Sensitization to Penicillin V with Tolerance to Other Betalactams
Recent Patents on Inflammation & Allergy Drug Discovery Amyloid Beta Protein as a Marker or Risk Factor of Alzheimers Disease
Current Alzheimer Research Recent Advances in Rational Diagnosis and Treatment of Normal Pressure Hydrocephalus: A Critical Appraisal on Novel Diagnostic, Therapy Monitoring and Treatment Modalities
Current Drug Targets Treatment of CNS Malignancies with a Recombinant Oncolytic Poliovirus
Drug Design Reviews - Online (Discontinued) Gene Therapy to Improve Pancreatic Islet Transplantation for Type 1 Diabetes Mellitus
Current Diabetes Reviews Comparative Time-Kill Study of Doxycycline, Tigecycline, Cefazolin and Vancomycin Against Several Clones of Staphylococcus aureus
Current Clinical Pharmacology Entropy Model for Multiplex Drug-Target Interaction Endpoints of Drug Immunotoxicity
Current Topics in Medicinal Chemistry Ecological Infectomics (Ecoinfectomics): Symbiotic Solutions to Microbial Infections
Anti-Infective Agents Nanostructures as Promising Tools for Delivery of Antimicrobial Peptides
Mini-Reviews in Medicinal Chemistry